Details for New Drug Application (NDA): 088452
✉ Email this page to a colleague
NDA 088452 describes METHYCLOTHIAZIDE AND DESERPIDINE, which is a drug marketed by Watson Labs and is included in two NDAs. Additional details are available on the METHYCLOTHIAZIDE AND DESERPIDINE profile page.
The generic ingredient in METHYCLOTHIAZIDE AND DESERPIDINE is deserpidine; methyclothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; methyclothiazide profile page.
The generic ingredient in METHYCLOTHIAZIDE AND DESERPIDINE is deserpidine; methyclothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; methyclothiazide profile page.
Summary for 088452
| Tradename: | METHYCLOTHIAZIDE AND DESERPIDINE |
| Applicant: | Watson Labs |
| Ingredient: | deserpidine; methyclothiazide |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.5MG;5MG | ||||
| Approval Date: | Aug 10, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
